Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02328794 · ClinicalTrials.gov registry record · NA
Randomized Clinical Trial to Reduce Harm From Tobacco
A NA study of Smoking Cessation, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 6,006
- Enrollment target
- 1
- Study location
NCT02328794 is a NA study of Smoking Cessation that has completed, run by University of Pennsylvania. The registered enrollment target is 6,006 participants, above the 443-participant average among 188 other Smoking Cessation trials with a reported enrollment target (1256% higher). The trial reports 1 study location across 1 state.
The verdict
NCT02328794, a NA study of Smoking Cessation, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 6,006 participants
- Enrollment target
- 1
- Study location
Study Summary
Using the NIH-funded Way to Health platform, the investigators will conduct this smoking cessation RCT among Vitality/Discovery beneficiaries. The investigators will be able to determine the effectiveness of 4 different interventions aimed at smoking cessation, two of which are incentive structures that are each grounded in behavioral economic principles. The other interventions will determine the effectiveness of various cessation aids, including electronic cigarettes and text messaging, on smoking cessation. This study will be conducted as an opt-out procedure where participants are automatically enrolled in the program but have the choice to unenroll if they so chose. This pragmatic approach will allow us to investigate the effects of such programs in an employee based population that can be easily mimicked in other employee based populations.
Conditions Studied
Interventions
- BEHAVIORAL Control
- BEHAVIORAL E-cigarette free access
- BEHAVIORAL E-cigarette/NRT/Zyban/Chantix Choice
- BEHAVIORAL Outcome Incentive arm
- BEHAVIORAL Loss framing incentive arm
Study Locations (1)
Pennsylvania
- University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6,006 participants |
| Start Date | 2015-01-01 |
| Est. Completion | 2017-04-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02328794
The ClinicalTrials.gov registry entry for NCT02328794 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 6,006 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 443-participant average among 188 other Smoking Cessation trials with a reported enrollment target (1256% higher). The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Smoking Cessation appearing as the primary indexed condition, and to 5 interventions - of which Control is the first listed.
NCT02328794 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT02328794 about?
NCT02328794 is a clinical study titled "Randomized Clinical Trial to Reduce Harm From Tobacco". Using the NIH-funded Way to Health platform, the investigators will conduct this smoking cessation RCT among Vitality/Discovery beneficiaries. The investigators will be able to determine the effectiveness of 4 different interventions aimed at smoking cessation, two of which are incentive structures ...
What is the current status of trial NCT02328794?
This trial is currently completed. It is a NA study. The enrollment target is 6,006 participants. The study started on 2015-01-01. Estimated completion is 2017-04-20.
What conditions does trial NCT02328794 study?
This clinical trial studies the following conditions: Smoking Cessation.
What interventions are being tested in trial NCT02328794?
The interventions under investigation include: Control (BEHAVIORAL), E-cigarette free access (BEHAVIORAL), E-cigarette/NRT/Zyban/Chantix Choice (BEHAVIORAL), Outcome Incentive arm (BEHAVIORAL), Loss framing incentive arm (BEHAVIORAL).
Who is sponsoring clinical trial NCT02328794?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02328794 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Smoking Cessation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Clinical Research Evaluating Smoking Cessation With E-Cigarettes and Nicotine Therapy
RECRUITING · NA
-
Scalable TELeheaLth Cancer CARe: The STELLAR Program to Treat Cancer Risk Behaviors
RECRUITING · NA
-
ACT Lung Health Intervention: Phase Two
RECRUITING · NA
-
Refer2Quit: Evaluating a Proactive, Tailored, Population Health Approach for Tobacco Treatment for Household Smokers Through a Pediatric Care Network
RECRUITING · NA
-
Baby Steps III: Testing a Clinician and Patient Intervention to Promote Smoking Cessation Among Pregnant Women
RECRUITING · NA
-
Urban and Reservation Implementation of All Nations Breath of Life
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.